Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more
Medtronic
Medtronic touts 7-year follow-up data on 2-level Prestige LP disc
Medtronic (NYSE:MDT) today released 7-year follow-up data from a study of its 2-level Prestige LP cervical disc, touting favorable clinical outcomes and patient satisfaction with the system. Medtronic touts the study as the longest patient follow-up data ever for U.S. 2-level cervical disc patients. The data was presented at the 84th Annual Meeting of the American […]
UnitedHealth names Medtronic as preferred insulin pump vendor, dealing blows to Tandem, Insulet, DexCom
Update: Updated with analyst information on Insulet and DexCom, and Insulet’s response. Tandem Diabetes Care (NSDQ:TNDM) shares dropped over 20% after UnitedHealth Group (NYSE:UNH) announced it is making Medtronic (NYSE:MDT) its preferred provider of insulin pumps. Insulet (NSDQ:PODD) and Dexcom Inc. (NSDQ:DXCM) also took a hit with the news, seeing shares drop 10% and 3% respectively The shift will go into […]
Medtronic wins FDA clearance for StrataMR valves
Medtronic (NYSE:MDT) today said it won FDA clearance for its StrataMR valves and shunts for patients with hydrocephalus and cerebrospinal fluid conditions. The clearance allows the valves and shunts to be used during MRI scans at their performance level setting at up to 3.0 Tesla, Fridley, Minn.-based Medtronic said. StrataMR is slated to be available “in the […]
FDA approves afib-detecting Visia ICD from Medtronic
Medtronic (NYSE:MDT) said it won FDA approval for its Visia AF line of implantable cardioverter defibrillators, which are designed to detect and monitor atrial fibrillation symptoms. Fridley, Minn.-based Medtronic said it plans to have the Visia AF MRI SureScan and Visia AF single-chamber ICDs on the market in early summer. The devices won CE Mark approval in the European Union […]
Medtronic, Masimo split win in PTAB decision
Masimo (NSDQ:MASI) said this week the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board delivered split a decision related to pulse oximetry technology patents owned by Masimo that were challenged last year by Medtronic (NYSE:MDT). The PTAB ruled on petitions to review 2 different patents owned by Masimo related to signal processing apparati, granting Medtronic’s […]
Medtronic touts VenaSeal data
Medtronic (NYSE:MDT) today released clinical data from a study of its VenaSeal closure system, claiming consistent long-term durability and improved quality of life in patients with venous reflux disease treated with the system The VenaSeal system from the Fridley, Minn.-based medical giant uses a proprietary medical adhesive to close superficial veins in lower extremities in patients […]
Medtronic touts Endurant stent graft data, lowered mortality
Medtronic (NYSE:MDT) today released data from the Engage global registry study of its Endurant abdominal aortic aneurysm stent graft, touting lowered mortality and rupture rates compared to the earlier Evar 1 trial. Data from the studies was presented at the 2016 Charing Cross Symposium in London, Fridley, Minn.-based Medtronic said. “In the comparison analysis of Engage and […]
Medtronic touts multi-trial In.Pact Admiral data
Medtronic (NYSE:MDT) today released a bevy of new data from clinical studies of its In.Pact Admiral drug coated balloon designed for treating peripheral artery disease. The Fridley, Minn.-based released data from 3 different studies of its In.Pact Admiral DCB at the 2016 Charing Cross Symposium meeting in London, including 1-year results from a chronic total occlusion imaging […]
C.R. Bard settles clutch of pelvic mesh lawsuits
A West Virginia federal judge yesterday dismissed nearly 150 product liability lawsuits brought against C.R. Bard (NYSE:BCR) over its pelvic mesh products, after an appeals court earlier this year upheld a $2 million verdict against the company in another suit. Judge Joseph Goodwin of the U.S. District Court for Southern West Virginia, who’s overseeing the multi-district […]
Urologix successor details dissolution plans
The successor to Urologix said today that it plans to completely dissolve during 2017, spelling the end for the Minneapolis-based urology device maker. Urologix, which made the Cooled ThermoTherapy and Prostiva RF devices to treat benign prostatic hyperplasia, licensed Prostiva from Medtronic (NYSE:MDT). But after running up a $2.8 million tab on its Twin Cities neighbor, Urologix couldn’t come up […]